Table 4.
Findings Summary
| ||||
---|---|---|---|---|
Drug-Route Dyad | Complexity Score | Mean (seconds) | SD (seconds) | Resources Utilized Per Verified Order |
Senna PO | low | 2.9 | 6 | 0 |
Atorvastatin PO | low | 3.1 | 4.3 | 0.2 |
Aspirin PO | low | 6.5 | 9.3 | 0.43 |
Cefazolin IV | low | 19.4 | 22.9 | 1 |
Dexamethasone IV | moderate | 14 | 14.8 | 0.3 |
Piperacillin-tazobactam IV | moderate | 33.4 | 26.2 | 1.37 |
Fentanyl IV | high | 13.7 | 16.3 | 0.17 |
Amiodarone IV | high | 15.3 | 18.9 | 0.53 |
Norepinephrine IV | high | 19.8 | 22.5 | 0.33 |
Morphine IV | high | 25.5 | 31.3 | 1.03 |
Amount of Time Saved with Low Complexity Group | ||||
Drug-Route Dyad | Mean (seconds) | Annualized Volume of Orders | Time Saved per Year (Sec; hours) | Time Saved per Month (Sec; hours) |
Senna PO | 2.9 | 37 062 | 107 480; 29.85 | 8957; 2.49 |
Atorvastatin PO | 3.1 | 11 220 | 34 782; 9.7 | 2899; 0.81 |
Aspirin PO | 6.5 | 23 580 | 153 270; 42.58 | 12 773; 3.55 |
Cefazolin IV | 19.4 | 21 132 | 409 960; 113.88 | 34 163; 9.49 |
Totala | 31.9 | 92 994 | 705 492; 196.01 | 58 791; 16.33 |
Mean-12.5, volume-71 862, Time/year-295 532; 82.1, Time/month-24 627.67; 6.84 if cefazolin totals excluded.